Short answer
Acadia Healthcare Company Inc (ACHC) filed its Q3 2016 10-Q quarterly report on Nov 2, 2016 for the quarter ended Sep 30, 2016.
Acadia Healthcare Company Inc Q3 2016 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $734.7M, up 53.2% YoY from $479.7M, driven primarily by Priory and other acquisitions
- Continuing-operations margin: negative 16.1% vs 6.1% YoY, including $174.7M divestiture loss
- NHS revenue $278.5M, up from $97.0M YoY, strongest payor growth; Other revenue $8.7M vs $11.8M, weakest
- Cash $27.8M vs $11.2M at December 31; operating cash flow $265.2M, acquisitions $683.3M and capital expenditures $250.0M
- Outlook: approximately 800 new beds expected in 2016; CMA approval and £320M U.K. divestiture pending, with Brexit and GBP weakness headwinds
Risk Factors
- Newly updated regulatory risk: CMA review of Priory acquisition could enter phase 2, delaying business integration
- Divestiture risk: Sale to BC Partners covers 22 U.K. facilities and approximately 1,000 beds
- Regulatory compliance risk: CMA approval expected by November 18, 2016, but may not occur
- Operational risk: Delayed Priory integration could prevent achievement of acquisition expectations
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Acadia Healthcare Company Inc quarterly reports
- Q3 2019 10-QFiled Nov 6, 2019
- Q2 2019 10-QFiled Jul 31, 2019
- Q1 2019 10-QFiled May 1, 2019
- Q3 2018 10-QFiled Nov 6, 2018
- Q2 2018 10-QFiled Jul 31, 2018
- Q1 2018 10-QFiled May 3, 2018
- Q3 2017 10-QFiled Oct 25, 2017
- Q2 2017 10-QFiled Jul 28, 2017
- Q1 2017 10-QFiled Apr 26, 2017
- Q2 2016 10-QFiled Jul 29, 2016
- Q1 2016 10-QFiled Apr 29, 2016
- Q3 2015 10-QFiled Nov 4, 2015
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.